Insider filing · BEAM
John M. Evans
CEO
profile →
Beam Therapeutics Inc.
BEAM · Healthcare · 25 filings in 24 months
ticker →
John M. Evans sold $1.5M of Beam Therapeutics (BEAM)
Executed Sep 30 2024, disclosed Oct 2 2024, 2 days later.
Value, as filed
$1.5M
60,000 sh × $24.60
Executed
Sep 30 2024
the trade date, as filed
Disclosed
Oct 2 2024
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JEJohn M. Evans (CEO) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales, 1 filed past the two-business-day deadline), most often in Beam Therapeutics Inc. (BEAM). The largest single filing was $1.7M of BEAM (48,100 sh across 3 lots, as filed), executed Jun 29.
The name
BEAMHealthcare · Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from seri…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by John M. Evans in BEAM
BEAMSALE
Beam Therapeutics Inc.
$1.7M48,100 sh across 3 lots
Exec Jun 29
Filed Jul 1 · 4:05 PM ET BEAMSALE Beam Therapeutics Inc. $739K
30,078 sh × $24.58
Exec Apr 1
Filed Apr 6 · 5:30 PM ET † BEAMSALE Beam Therapeutics Inc. $1.1M
50,000 sh across 2 lots
Exec Mar 30
Filed Apr 1 · 5:30 PM ET BEAMSALE Beam Therapeutics Inc. $1.4M
47,094 sh across 3 lots
Exec Jan 29
Filed Feb 2 · 5:30 PM ET BEAMSALE Beam Therapeutics Inc. $1.2M
50,000 sh across 2 lots
Exec Oct 1 2025
Filed Oct 3 2025 · 5:30 PM ET BEAMSALE Beam Therapeutics Inc. $563K
30,663 sh × $18.35
Exec Apr 1 2025
Filed Apr 3 2025 · 5:30 PM ET BEAMSALE Beam Therapeutics Inc. $797K
29,800 sh × $26.75
Exec Jan 30 2025
Filed Feb 3 2025 · 5:30 PM ET